Taxol: twenty years later, the story unfolds.

作者信息

Rowinsky E K, Donehower R C

出版信息

J Natl Cancer Inst. 1991 Dec 18;83(24):1778-81. doi: 10.1093/jnci/83.24.1778.

DOI:10.1093/jnci/83.24.1778

PMID:1683907

Abstract

摘要

相似文献

Taxol: twenty years later, the story unfolds.

J Natl Cancer Inst. 1991 Dec 18;83(24):1778-81. doi: 10.1093/jnci/83.24.1778.

Taxol.

Lancet. 1992 Jun 13;339(8807):1447-8.

Clinical trials referral resource. Clinical trials with taxol.

Oncology (Williston Park). 1992 Mar;6(3):67-70.

Taxol: an important new drug in the management of epithelial ovarian cancer.

Yale J Biol Med. 1991 Nov-Dec;64(6):583-90.

[Taxol and ovarian adenocarcinomas].

Pathol Biol (Paris). 1992 Nov;39(9):834-5.

Taxol improves outlook for lung, breast, and ovarian cancer.

Oncology (Williston Park). 1992 Aug;6(8):16.

[Paclitaxel (taxol): a review of its antitumor activity and toxicity in clinical studies].

Gan To Kagaku Ryoho. 1998 Mar;25(4):605-15.

Sequences of taxol and cisplatin: a phase I and pharmacologic study.

J Clin Oncol. 1991 Sep;9(9):1692-703. doi: 10.1200/JCO.1991.9.9.1692.

Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer.

Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-40-S15-43.

Taxol in the management of cancers of the breast and the ovary.

Cancer Invest. 2000;18(3):242-60. doi: 10.3109/07357900009031828.

引用本文的文献

The Persistent Power of the Taxane/Platin Chemotherapy.

Cancers (Basel). 2025 Apr 2;17(7):1208. doi: 10.3390/cancers17071208.

Antibody-drug conjugates come of age in oncology.

Nat Rev Drug Discov. 2023 Aug;22(8):641-661. doi: 10.1038/s41573-023-00709-2. Epub 2023 Jun 12.

Rationale for combination of paclitaxel and CDK4/6 inhibitor in ovarian cancer therapy - non-mitotic mechanisms of paclitaxel.

Front Oncol. 2022 Sep 15;12:907520. doi: 10.3389/fonc.2022.907520. eCollection 2022.

Paclitaxel plus platinum or gemcitabine plus platinum in first-line treatment of advanced non-small-cell lung cancer: results from 6 randomized controlled trials.

Int J Clin Oncol. 2013 Dec;18(6):1005-13. doi: 10.1007/s10147-012-0502-9. Epub 2012 Dec 6.

Taccalonolides: Novel microtubule stabilizers with clinical potential.

Cancer Lett. 2010 May 1;291(1):14-9. doi: 10.1016/j.canlet.2009.09.020. Epub 2009 Oct 31.

Reversal of Taxol resistance in hepatoma by cyclosporin A: involvement of the PI-3 kinase-AKT 1 pathway.

Br J Cancer. 2003 Mar 24;88(6):973-80. doi: 10.1038/sj.bjc.6600788.

Growth-inhibiting effects of taxol on human liver cancer in vitro and in nude mice.

World J Gastroenterol. 2000 Apr;6(2):210-215. doi: 10.3748/wjg.v6.i2.210.

Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel.

Br J Cancer. 1999 Oct;81(3):416-22. doi: 10.1038/sj.bjc.6690710.

Phase I and pharmacokinetic study of paclitaxel by 24-hour intravenous infusion.

Jpn J Cancer Res. 1994 Oct;85(10):1057-62. doi: 10.1111/j.1349-7006.1994.tb02906.x.

Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro.

Br J Cancer. 1994 Feb;69(2):299-306. doi: 10.1038/bjc.1994.55.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验